Authors:
Malmqvist, K
Kahan, T
Edner, M
Held, C
Hagg, A
Lind, L
Muller-Brunotte, R
Nystrom, F
Ohman, KP
Osbakken, MD
Ostergren, J
Citation: K. Malmqvist et al., Regression of left ventricular hypertrophy in human hypertension with irbesartan, J HYPERTENS, 19(6), 2001, pp. 1167-1176
Authors:
Kurland, L
Melhus, H
Karlsson, J
Kahan, T
Malmqvist, K
Ohman, KP
Nystrom, F
Hagg, A
Lind, L
Citation: L. Kurland et al., Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients, J HYPERTENS, 19(10), 2001, pp. 1783-1787
Authors:
zur Muhlen, BV
Kahan, T
Hagg, A
Millgard, J
Lind, L
Citation: Bv. Zur Muhlen et al., Treatment with irbesartan or atenolol improves endothelial function in essential hypertension, J HYPERTENS, 19(10), 2001, pp. 1813-1818
Authors:
Millgard, J
Hagg, A
Kahan, T
Landelius, J
Malmqvist, K
Sarabi, M
Lind, L
Citation: J. Millgard et al., Left ventricular hypertrophy is associated with an attenuated endothelium dependent vasodilation in hypertensive men, BLOOD PRESS, 9(6), 2000, pp. 309-314
Authors:
Sarabi, M
Lind, L
Millgard, J
Hanni, A
Hagg, A
Berne, C
Lithell, H
Citation: M. Sarabi et al., Local vasodilatation with metacholine, but not with nitroprusside, increases forearm glucose uptake, PHYSL RES, 48(4), 1999, pp. 291-295
Authors:
Eriksson, H
Eriksson, UG
Frison, L
Hansson, PO
Held, P
Holmstrom, M
Hagg, A
Jonsson, T
Lapidus, L
Leijd, B
Stockelberg, D
Safwenberg, U
Taghavi, A
Thorsen, M
Citation: H. Eriksson et al., Pharmacokinetics and pharmacodynamics of melagatran, a novel synthetic LMWthrombin inhibitor, in patients with acute DVT, THROMB HAEM, 81(3), 1999, pp. 358-363
Authors:
Sarabi, M
Millgard, J
Hagg, A
Ridefelt, P
Henriksson, J
Lind, L
Citation: M. Sarabi et al., Endothelin plays an important role in the endothelium-dependent vasodilatation in the human forearm, SC J CL INV, 59(1), 1999, pp. 17-22